2024-05-02 06:33:15 ET
Fiscal 2024 Guidanceas of May 2, 2024 | Fiscal 2024 Guidanceas of Feb 1, 2024 | |
Total Revenues | ~$20.1 to $20.3 billion | ~$20.2 to $20.4 billion |
Organic Revenue Growth ( FXN ) | 5.5% to 6.25% | 5.5% to 6.25% |
Impact of Surgical Instrumentation Platform Divestiture | (~75) basis points | (~75) basis points |
Revenue Growth ( FXN ) | 4.75% to 5.5% | 4.75% to 5.5% |
Estimated Foreign Currency Impact to Revenue Growth | (~65) basis points | (~25) basis points |
Adjusted Diluted EPS | $12.95 to $13.15 | $12.82 to $13.06 |
Adjusted Diluted EPS Growth | 6.1% to 7.7% | ~5% to 7% |
Estimated Impact of Surgical Instrumentation PlatformDivestiture included in Adjusted Diluted EPS | (~75) basis points | (~75) basis points |
Estimated Foreign Currency Impact included in AdjustedDiluted EPS | (~425) basis points | (~360) basis points |
Read the full article on Seeking Alpha
For further details see:
Becton, Dickinson reports Q2 results, raises guidance